Sodium Methyl Paraben

About

What it is and where it shows up.

Sodium methyl paraben is the water-soluble sodium salt of methyl paraben, an ester of p-hydroxybenzoic acid, used as an antimicrobial preservative effective against bacteria, moulds, and yeasts in foods, beverages, pharmaceuticals, and cosmetics. It is chemically stable, non-volatile, and active across a broad pH range, making it one of the most widely used food and pharmaceutical preservatives globally.

Safety summary

The regulatory and scientific consensus.

EFSA and JECFA have established a group ADI of 0–10 mg/kg body weight per day for methyl and ethyl parabens and their sodium salts; animal studies found no evidence of developmental toxicity even at the highest tested doses. Weak estrogenic activity has been detected in vitro, but potency is far lower than that of natural oestrogens and no human studies have confirmed significant hormone disruption, breast cancer, or carcinogenic effects at typical dietary exposures. Neonates and infants are a specific sensitive population in whom the ADI may be exceeded through cumulative exposure across drug, food, and cosmetic sources.

Regulatory landscape

What food-safety regulators have decided.

Jurisdiction	Status	Note
Health Canada (Canada)	Restricted	Methyl paraben and its sodium salt are listed in Part 2 of the List of Permitted Preservatives at a maximum of 1000 ppm (0.1%) in certain foods and beverages. Health Canada adopts the JECFA group ADI of 0–10 mg/kg bw/day for the sum of methyl and ethyl parabens and their sodium salts. Health Canada concluded no safety concern based on current reported industry use levels.source
EFSA (European Food Safety Authority) (European Union)	Restricted	Permitted as food additive E219 (sodium methyl p-hydroxybenzoate) in four categories of processed foods under Directive 95/2/EC. The group ADI of 0–10 mg/kg bw/day applies to the sum of methyl paraben, ethyl paraben, and their sodium salts; propyl paraben and its sodium salt were excluded from this group ADI in 2004 due to lack of a clear NOAEL.source
FDA (Food and Drug Administration) (United States)	Approved	Methyl paraben and its sodium salt are recognised as GRAS (Generally Recognized As Safe) under 21 CFR 184.1670, permitted as a direct food substance preservative at concentrations up to 0.1% in food. The sodium salt is covered under the same GRAS provisions as the parent acid per FDA interpretation.source

Who should approach with care

Whose guidance would steer them away.

Infants — Premature and newborn infants can easily exceed the ADI through combined exposure to paraben-containing drugs, foods, and cosmetics, and dose–response thresholds for adverse effects in this age group are uncertain; paraben-free alternatives should be sought for NICU patients.

Pregnancy — Parabens exhibit weak in-vitro estrogenic activity and have been linked to adverse reproductive outcomes in some studies, warranting precautionary limitation of unnecessary exposure during pregnancy.

Lactation — Parabens are detectable in human tissue and body fluids; as a precautionary measure given the weak estrogenic concern and the sensitivity of the nursing infant, minimising unnecessary intake during lactation is advisable.

Research citations

The sources behind this verdict.

1PubMed. A perspective on the safety of parabens as preservatives in wound care products. pmc.ncbi.nlm.nih.gov
2PubMed. Application of grouping and read-across for the evaluation of parabens of different chain lengths with a particular focus on endocrine properties. pmc.ncbi.nlm.nih.gov
3PubMed. Paraben exposure through drugs in the neonatal intensive care unit: a regional cohort study, 2023. pmc.ncbi.nlm.nih.gov
4EFSA. Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food related to para hydroxybenzoates (E 214–219), 2004. efsa.europa.eu
5WHO. JECFA Evaluation of Parabens — 17th Report (1974) and 2006 Amendment, 1974. canada.ca

Independently researched5 citations